2 results
Approved WMOCompleted
To confirm the safety of the Articulinx ICC by evaluating device- and procedure relates adverse events.
Approved WMOWill not start
To evaluate the long-term safety and tolerability of elsubrutinib and upadacitinib given alone or as the ABBV-599 (elsubrutinib/upadacitinib) combination in SLE subjects who have completed the M19-130 Phase 2 study.